Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by fredgoodwinsonon Oct 06, 2019 6:47am

141 Views

Post# 30200776

RE:RE:RE:RE:RE:RE:RE:The Seeking Alpha article from two years ago

Can`t recall precisely RS but will try and look. Easy to backtrack through anns but some things were said at the AGM or in Presentations and some things on Korelin but from memory there were words categorically to the effect that the requirement for a Phase III could be entirely obviated by the sort of outstanding safety and efficacy results that we are anticipating from Phase II.

Bullboard Posts

Soma Gold poised to extend profitable track record